Analysis of workflow and time to treatment and the effects on outcome in endovascular treatment of acute ischemic stroke: Results from the SWIFT PRIME randomized controlled trial

Radiology

Volumn 279, Issue 3, 2016, Pages 888-897

  Goyal, Mayank ^a   Jadhav, Ashutosh P ^b   Bonafe, Alain ^c   Diener, Hans ^d   Pereira, Vitor Mendes ^e   Levy, Elad ^f   Baxter, Blaise ^g   Jovin, Tudor ^b   Jahan, Reza ^h   Menon, Bijoy K ^a   Saver, Jeffrey L ^h   Devlin, Thomas ⁱ   Reddy, Vivek ^b   Siddiqui, Adnan ^c,j   De Rochemont, Richard Du Mesnil ^k   Nogueira, Raul ^l   Lopes, Demetrius ^m   Carpenter, Jeffrey ⁿ   Weimar, Christian ^d   Reimann, Gernot ^o   Clark, Wayne ^p   Budzik, Ronald ^q   Hussain, M Shazam ^r   Ringleb, Peter ^s   Acosta, Indrani ^t   Ecker, Robert ^u   Ramsey, Christian ^v   Papanagiotou, Panagiotis ^w   Fitzsimmons, Brian Fred ^x   Deshmukh, Vivek ^y   Hassan, Ameer ^z   Jansen, Olav ^aa   Remonda, Luca ^ab   Starkman, Sid ^ac   Yavagal, Dileep ^ad   Arenillas, Juan ^ae   Brekenfeld, Casper ^af   Jagadeesan, Bharathi ^ag   Deshaies, Eric ^ah   Jumaa, Mouhammad ^ai   Puri, Ajit ^aj   Martin, Coleman ^ak   Farid, Hamed ^al   Malek, Ali ^am   Hansen, Klaus ^an   Killer Oberpfalzer, Monika ^ao   Prothmann, Sascha ^ap   Haring, Hans Peter ^aq   Andersen, Grethe ^ar   more..

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c GUI DE CHAULIAC HOSPITAL   (France)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e TORONTO WESTERN HOSPITAL   (Canada)

^f UNIVERSITY AT BUFFALO   (United States)

^g UNIVERSITY OF TENNESSEE AT CHATTANOOGA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Neurologic Research and Erlanger Hospital   (United States)

^j UNIVERSITY AT BUFFALO   (United States)

^k UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^l EMORY UNIVERSITY   (United States)

^m RUSH UNIVERSITY MEDICAL CENTER   (United States)

ⁿ WEST VIRGINIA UNIVERSITY   (United States)

^o KLINIKUM DORTMUND   (Germany)

^p OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^q RIVERSIDE METHODIST HOSPITAL   (United States)

^r LERNER RESEARCH INSTITUTE   (United States)

^s UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^t FLORIDA HOSPITAL   (United States)

^u MAINE MEDICAL CENTER   (United States)

^v CENTRAL BAPTIST HOSPITAL   (United States)

^w KLINIKUM BREMEN MITTE   (Germany)

^x FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^y Providence Brain and Spine Institute   (United States)

^z Valley Baptist Medical Center   (United States)

^aa UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^ab CANTONAL HOSPITAL AARAU   (Switzerland)

^ac UCLA MEDICAL CENTER   (United States)

^ad JACKSON MEMORIAL HOSPITAL   (United States)

^ae HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^af UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^ag HENNEPIN COUNTY MEDICAL CENTER   (United States)

^ah SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^ai TOLEDO HOSPITAL   (United States)

^aj UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^ak Mid America Heart Institute Saint Luke's Hospital   (United States)

^al ST JUDE MEDICAL CENTER   (United States)

^am Tenet Health Systems   (United States)

^an Rigshospitalet   (Denmark)

^ao Christian Doppler Klinik   (Austria)

^ap TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^aq KEPLER UNIVERSITY HOSPITAL   (Austria)

^ar AARHUS UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BINOMIAL DISTRIBUTION; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CONTROLLED STUDY; EMERGENCY WARD; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT TRANSPORT; PERCUTANEOUS THROMBECTOMY; PERFUSION; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; PUNCTURE; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; SYMPTOM; THERAPY DELAY; TIME TO TREATMENT; TREATMENT OUTCOME; WORKFLOW; ACUTE DISEASE; INFORMED CONSENT; INTRAVENOUS DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; STATISTICAL MODEL; STROKE; THROMBECTOMY; TIME FACTOR;

ACUTE DISEASE; ADMINISTRATION, INTRAVENOUS; COMBINED MODALITY THERAPY; HUMANS; INFORMED CONSENT; LOGISTIC MODELS; STROKE; THROMBECTOMY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; WORKFLOW;

EID: 84995457241     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2016160204     Document Type: Article

References (15)

1. Khatri P, Yeatts SD, Mazighi M, et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol 2014;13(6):567-574.
2. Menon BK, Almekhlafi MA, Pereira VM, et al. Optimal workflow and process-based performance measures for endovascular therapy in acute ischemic stroke: analysis of the Solitaire FR Thrombectomy for Acute Revascularization study. Stroke 2014;45(7):2024-2029.
3. Kidwell CS, Jahan R, Saver JL. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368(25):2434-2435.
4. Ciccone A, Valvassori L; SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368(25):2433-2434.
5. Broderick JP, Tomsick TA, Palesch YY. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368(25):2432-2433.
6. Goyal M, Almekhlafi MA, Fan L, et al. Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the Interventional Management of Stroke III trial. Circulation 2014; 130(3):265-272.
7. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006;355(22):2308-2320.
8. Saver JL, Goyal M, Bonafe A, et al. Solitaire ™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke. Int J Stroke 2015;10(3):439-448.
9. Saver JL, Goyal M, Bonafe A, et al. Stentretriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015;372(24):2285-2295.
10. Almekhlafi MA, Eesa M, Menon BK, Demchuk AM, Goyal M. Ultrashort imaging to reperfusion time interval arrests core expansion in endovascular therapy for acute ischemic stroke. J Neurointerv Surg 2013; 5(Suppl 1):i58-i61.
11. Saver JL, Fonarow GC, Smith EE, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 2013;309(23):2480-2488.
12. Khatri P, Abruzzo T, Yeatts SD, et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73(13):1066-1072.
13. Prabhakaran S, Ward E, John S, et al. Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke 2011;42(6):1626-1630.
14. McTaggart RA, Ansari SA, Goyal M, et al. Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of Neurointerventional Surgery. J Neurointerv Surg 2015 Aug 31. [Epub ahead of print]
15. Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372(11):1019-1030.